Aortic Dissection Clinical Trial
Official title:
The Mechanism Research of Angiotensin II Pathway and Postoperative Hypoxemia
NCT number | NCT05055570 |
Other study ID # | 2021107X |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | August 12, 2021 |
Est. completion date | June 1, 2022 |
Verified date | April 2023 |
Source | Beijing Anzhen Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Acute type A aortic dissection is often accompanied by postoperative hypoxemia, the cause of which is not fully understood. Angiotensin II is an important component of the renin-angiotensin system (RAS), which has been suggested to be involved in the development of aortic dissection and pulmonary inflammation.The purpose of this study was to investigate the role and mechanism of angiotensin II pathway in postoperative hypoxemia after acute type A aortic dissection, and to provide reference for clinical application
Status | Completed |
Enrollment | 88 |
Est. completion date | June 1, 2022 |
Est. primary completion date | June 1, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - patients undergoing surgery for acute type A aortic dissection - age between 18 to 80 Exclusion Criteria: - perioperative severe cardiac insufficiency - rejection of consent |
Country | Name | City | State |
---|---|---|---|
China | Anzhen hospital, Beijing | Beijing | Beijing |
Lead Sponsor | Collaborator |
---|---|
Beijing Anzhen Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The Difference Concentrations of ANG II in Serum Between Patients With and Without Postoperative Hypoxemia. | Blood samples were taken within 24 hours after operation to detect the contents of ANG II in serum. Postoperative hypoxemia is defined by the oxygenation index (OI), which is the ratio of arterial partial pressure of oxygen to fraction inspired oxygen (PaO2 / FiO2), of less than or equal to 200 for two consecutive times within the first 24 h after operation | Within 24 hours after surgery | |
Secondary | The Risk Factors for Postoperative Hypoxemia in Stanford Type A Acute Aortic Dissection Patients. | Basic characteristics, intraoperative details, biochemical parameters and outcome results were obtained, and blood was collected within 24 hours after surgery for the measurement of ANG II, sACE2 and mir-145 concentrations. Univariate analysis was first performed to identify the potential risk factors for postoperative hypoxemia. Multivariate logistic regression analysis was performed for factors with P < 0.05 or that were considered clinically important. | up to 60 days | |
Secondary | Duration of Stay in the Intensive Care Unit | Duration of Stay in the intensive care unit after surgery | up to 60 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05582967 -
The DAShED (Diagnosis of Aortic Syndrome in the ED) Study
|
||
Terminated |
NCT04116684 -
Digital Home Blood Pressure Monitoring in Type B Aortic Dissection Patients
|
N/A | |
Completed |
NCT02086136 -
Aortic Dissection Detection Risk Score Plus D-dimer in Suspected Acute Aortic Dissection
|
||
Recruiting |
NCT02201589 -
Feasibility of Endovascular Repair Of Ascending Aortic Pathologies
|
N/A | |
Recruiting |
NCT03948555 -
Magnetic Resonance Imaging (MRI) for Aortic Dissection to Visualise Inflammation
|
||
Enrolling by invitation |
NCT05912608 -
Optimal Strategy for Repair of Type A Acute Aortic Dissection
|
||
Recruiting |
NCT03707743 -
Registry of Patients With Acute/Subacute Type B Aortic Dissection Treated by Means of the STABILISE Technique (STABILISE)
|
||
Enrolling by invitation |
NCT00583817 -
Endovascular Treatment of Thoracic Aortic Disease
|
N/A | |
Recruiting |
NCT05073991 -
Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.
|
||
Not yet recruiting |
NCT02523300 -
Glucocorticoid on the Prognosis of TEVAR
|
N/A | |
Completed |
NCT01197651 -
Aortic-Stent-Register
|
N/A | |
Recruiting |
NCT04471909 -
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
|
N/A | |
Not yet recruiting |
NCT06044259 -
Study Comparing Hemiarch Replacement and Hemiarch Plus Stent Implantation in Acute Aortic Dissection
|
N/A | |
Completed |
NCT05039814 -
Prediction of Postoperative Acute Kidney Injury in Patients With Acute Type A Aortic Dissection Using Cystatin C
|
||
Recruiting |
NCT03780738 -
A Validation Study of The Relationship Between ALDH2 and Aortic Dissection
|
||
Completed |
NCT03647566 -
18F Sodium Fluoride PET/CT in Acute Aortic Syndrome
|
||
Enrolling by invitation |
NCT05800743 -
Evaluation of the GORE® Ascending Stent Graft
|
N/A | |
Recruiting |
NCT03347812 -
Clinical Study for Evaluating the Safety and Efficacy of Total Endovascular Aortic Arch Repair
|
N/A | |
Completed |
NCT05044494 -
Surgery for Delay-recognized or Defer-operated Type A Aortic Dissection
|
||
Terminated |
NCT02958098 -
My Research Legacy Pilot Study
|